Consistent with these findings, gel shift assays showed no change in nuclear protein binding to NF-κB oligonucleotides and there was no change in NF-κB-dependent reporter activity in muscles of control vs. C26 tumor bearing mice. This evidence concerns the gene NFKB1 and neoplasm.